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Tricho-dento-osseous syndrome (TDO), an uncommon form of ectodermal dysplasia is an autosomal dominant 
genetic disorder which is characterized by inherited defects in tissues arising from epithelial-mesenchymal inte-
raction. Genetic studies have revealed that it is caused by mutation in the DLX3 gene. TDO presents with a great 
phenotypic heterogeneity and studies have suggested that this heterogeneity is the result of environmental factors 
or other genetic modifiers. In this article, we report a case of TDO in which the child had typical clinical features 
of hair, teeth and bone defects, as seen in TDO. Parents of the child were unaffected. Genetic analysis of the child 
revealed mutation in DLX3 gene. The child also showed precocious eruption of the permanent molars, a clinical 
feature which has been rarely reported. We suggest that the precocious eruption seen in TDO is probably due to a 
markedly increased osteoblastic activity.




Ectodermal dysplasias (EDs) comprise a large, hetero-
geneous group of inherited disorders that are defined 
by primary defects in the development of two or more 
tissues derived from embryonic ectoderm. The tricho-
dento-osseous syndrome (TDO), OMIM #190320, is an 
uncommon form of ectodermal dysplasia. It is an auto-
somal dominant genetic disorder which is characterized 
by inherited defects in tissues arising from epithelial-
mesenchymal interaction; primarily the hair, teeth and 
bones from which the condition derives its name. The 
term “tricho-dento-osseous” (TDO) was first coined by 
Lichtenstein et al. in 1972 (1,2), although the first case 
was reported in 1966 by Robinson and co-workers (3). 
Genetic analysis in most studies has shown a mutation 
in the DLX3 gene (4).
Till date, literature reports three large kindreds and rela-
ted families in the United States (Virginia, North Caro-
lina, and Tennessee) (1,4,5) to be affected with TDO. In 
addition to these well documented kindreds, there have 
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been isolated case reports of TDO from all around the 
world (6). TDO presents with a great phenotypic hetero-
geneity which can make the diagnosis somewhat confu-
sing (7). The distinct, severe dental defects are the most 
reliable of all signs in TDO. Differentiating TDO from 
other types of dental defects such as hypomaturation 
hypoplastic amelogenesis imperfecta with taurodontism 
(AIHHT), both of which show overlapping clinical fea-
tures, is necessary so as to lead to discoveries about cau-
ses and bring about advances in treatment, which will 
ultimately lift all our collective hopes for the future.
The purpose of this article is to report an isolated case of 
tricho-dento-osseous syndrome in a child who had typi-
cal clinical features of the teeth, hair and bone defects, 
as seen in TDO. Genetic analysis of the child revealed a 
mutation in DLX3 gene, which is probably sporadic, as 
the parents of the child were not affected with TDO.  Be-
sides the typical clinical features, the child also showed 
precocious eruption of the permanent molars; a featu-
re which has been rarely reported. We suggest that the 
precocious eruption seen in TDO is probably due to a 
markedly increased osteoblastic activity.
Case Report
A 4 year old male child reported to our Department of 
Pedodontics and Preventive Dentistry with the chief 
complaint of discoloured teeth. Medical history was 
non-contributory. His mother gave a history of an un-
complicated, full-term pregnancy resulting from a non-
consanguineous marriage. 
On general examination, the child appeared well nouris-
hed. His measured height was 96.25cm. Parents reported 
normal mental development of the child. He had sparse, 
discoloured hair and had a history of 3-4 hair cuts. The 
child had a broad forehead which appeared prominent 
on lateral view.  The measured head circumference was 
51.25cm, which falls in the 50th percentile. There was 
no evident splitting of the superficial layer of finger nails 
or toe nails.
Dental examination (Fig. 1) revealed eruption of all 
four permanent first molars. Primary teeth had a history 
of extraction due to formation of dental abscess. The 
remaining primary teeth were opaque and yellowish-
brown in colour. Severe attrition of mandibular primary 
incisors and maxillary primary canines were seen. Pulp 
chambers of maxillary and mandibular primary canines 
were evident through the thin enamel layer. Both poste-
rior and anterior occlusal relationships revealed a Class 
III tendency.
Panoramic radiograph (Fig. 2) of the child showed in-
creased sclerosis of the mandibular cortical bone. All 
the remaining primary teeth and the erupted first perma-
nent molars appeared taurodontic. The enamel appeared 
extremely thin, the pulp chambers were enlarged with 
greater apico-occlusal height and the furcation was dis-
placed apically. Radiographic contrast between enamel 
and dentin was reduced. As root formation of the first 
permanent molars was not complete, an objective as-
sessment of taurodontism was not done.
Fig. 1. Intra-oral view showing severly attrited teeth, visible pulp 
chambers and class III anterior occlusal relationship.
Fig. 2. Panoramic radiograph showing taurodontic teeth and thick-
ened cortical bone.
Lateral cephalogram (Fig. 3) examination showed in-
creased density of the mandible (especially the sym-
physis region) and the base of the skull. Frontal sinus 
pneumatization was not very apparent. Cephalometric 
analysis revealed a Class III skeletal pattern because of 
a retrusive maxilla (reduced SNA).
Genetic analysis reports of the child revealed a 4-bp mu-
tation in the DLX3 gene.
The child’s parents had no abnormal hair, bone or dental 
findings and were apparently unaffected by the condi-
tion. Parents were made aware about the dental defects 
of the child and the associated condition. Counselling 
was done and they were explained about the need for 
regular follow ups. Extraction of symptomatic primary 
teeth was done. Stainless steel crowns were cemented 
on all four erupted permanent molars with glass ionomer 
cements after minimal crown preparation. Split acrylic 
removable denture was given for the maxillary arch. The 
patient provided their written informed consent.
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Fig. 3. Lateral cephalogram showing increased density of mandible 
and base of skull, reduced frontal sinus pneumatization and class III 
skeletal relationship.
Discussion
Tricho-dento-osseous (TDO) syndrome is a highly pe-
netrant, autosomal dominant genetic disorder which is 
characterized by inherited defects in tissues which arise 
from epithelial-mesenchymal interaction. As per studies 
(6), the minimal diagnostic criteria for TDO should in-
clude enamel hypoplasia, posterior teeth with taurodon-
tism, autosomal dominant inheritance pattern, tightly 
curly hair at birth and/or radiographic evidence of bone 
sclerosis.
As per early epidemiologic investigations, Shapiro (7) 
suggested classification of TDO into three subtypes, 
TDO - I, II and III, based on clinical and radiographical 
features. However, further studies (4) largely discounted 
this classification on genetic grounds and it has been su-
ggested that TDO is a condition with great phenotypic 
variation. Studies have also shown that TDO and AI-
HHT are genetically distinct conditions (6).
TDO syndrome is a genetic disorder arising because of 
a mutation in the DLX3 gene. This gene is a member 
of the DLX family (related to Drosophila distal-less 
gene, which is involved in head and limb development). 
DLX3 is located in a tail-to-tail configuration with ano-
ther member of the gene family (DLX7) on the long 
arm of chromosome 17, and encodes a homeodomain 
protein. Early DLX3 expression is localized to first and 
second branchial arches that will give rise to odontoblast 
and craniofacial structures. In the later stages of develo-
pment, it is expressed in tissues arising from epithelial-
mesenchymal interaction such as skin, hair follicles, otic 
and olfactory placodes, limb buds, placenta and tooth 
germs. Their main action in these tissues is to induce 
cellular differentiation by regulating gene expression 
through their DNA-recognition properties (8). For these 
ectodermally derived organs, DLX3 gene and p63 gene 
(master regulatory gene of multi-layered epithelia) act 
as a part of a series of regulatory cascades of differentia-
tion. Degradation of DNp63a, a specific product of the 
p63 gene, is induced by DLX3 expression (9).
Regarding the effect of DLX3 on mineralized tissue, its in-
fluence varies specifically according to the terminal diffe-
rentiation for each cell type. Direct involvement of DLX3 
has been shown in osteoprogenitor cells, where it promo-
tes the expression of bone matrix proteins such as type 
1 collagen, bone sialoprotein, osteocalcin, and alkaline 
phosphatase. The expression of osteocalcin and RUNX2 
is actually because of a combined action of DLX3, with 
DLX5 and MSX2 (10,11). Role of DLX3 has also been 
shown in osteoclastogenesis. Zhao et al. (10) investigated 
the effect of DLX3 on osteoclastogenesis and concluded 
that DLX3 is involved in the process of osteoclastic diffe-
rentiation through microRNA-124 and when compared to 
wild type DLX3, mutant DLX3 mutation had a stronger 
suppression on osteoclastogenesis. 
An increased DLX3 expression has also been shown du-
ring the osteogenic differentiation of neural crest derived 
stem cells of dental follicle (DFCs). Additional osteoge-
nic transcription factors such as MSX2, RUNX2, DLX5, 
or OSTERIX which are seen in osteoprogenitor cells, 
are not involved in osteogenic differentiation of DFCs, 
suggesting an important role of DLX3 in the progression 
of differentiation of these cells (8).
During tooth development, DLX3 has also been found 
to up-regulate the enamel matrix protein genes Amelx, 
Enam, Odam, and Klk4 (12). 
Mutant- DLX3 (responsible for TDO), disrupts all these 
regulatory functions. Disruption of odontoblastic cyto-
differentiation, which leads to odontoblast apoptosis has 
been shown in transgenic mice with mutant DLX3 (8). 
However, TDO patients do not exhibit overt skin phe-
notype. Costanzo et al. (9) suggested that co-expression 
of wild and mutant DLX3 in skin effectively regulates 
DNp63a protein level, thereby protecting patients from 
developing severe p63 associated skin abnormalities. 
To date, six DLX3 mutations are known to exist. In ge-
neral, missense mutations, which change conserved ami-
no acids in the homeodomain (129-188 amino acids), 
result in the most severe clinical phenotypes. Mayer et 
al. (13) reported a case with I175T mutation. Nieniman 
et al. (14) reported R133P and S182F mutation in two 
families of Finnish origin. Price et al [4] found that the 
TDO phenotype in all the six North Carolina families 
and the Virginia family was associated with a 4-bp dele-
tion in the DLX3 homeobox. They suggested that these 
families perhaps inherited this deletion mutation from 
a common ancestor. They also suggested that the clini-
cal heterogeneity was not genetic in nature, but was the 
result of environmental factors and/or other genetic mo-
difiers. Similarly, the 2-bp deletional mutation (15) has 
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been identified in multiple families with different ethni-
cities and with different phenotypic expressions.
In the present case, the child was probably a case of spo-
radic mutation of DLX3 gene as the parents of the child 
were unaffected by the condition. Besides the hair, teeth 
and bone defects, the child’s clinical and radiographic 
examination revealed frontal bossing, a class III skeletal 
pattern because of maxillary retrusion and precocious 
eruption of the permanent first molars.
Tooth eruption results from an interplay between osteo-
blastic and osteoclastic activity. A continuous remode-
lling process takes place around an erupting tooth. In the 
present case, the child had a normal dental age but had 
a markedly increased osteoblastic activity, as was evi-
dent by the significantly increased density of the mandi-
ble and the skull bones. A great increase in osteoblastic 
activity is perhaps responsible for precocious eruption. 
Literature has mostly reported cases of TDO associated 
with delayed eruption. We hypothesize that in cases of 
TDO syndrome, which present with increased osteoblas-
tic activity, there is a shift of equilibrium towards bone 
deposition all around the erupting tooth, and the con-
sequence is delayed eruption. But in cases which have 
highly increased osteoblastic activity, the large amount 
of bone deposition around the root region of the erup-
ting tooth will create sufficient pressure to disrupt the 
increased osteoblastic activity at the coronal end of the 
erupting tooth. This compressive mechanical force will 
stimulate osteoclast differentiation, resulting in preco-
cious eruption.
References
1. Lichtenstein L, Warson R. Syndrome of dental anomalies, curly hair, 
and sclerotic bone. Birth Defects Orig Artic Ser. 1971;7:308-11.
2. Lichtenstein J, Warson R, Jorgenson R, Dorst JP, McKusick VA. 
The tricho-dento-osseous (TDO) syndrome. Am J Hum Genet. 
1972;24:569-82.
3. Robinson GC, Miller JR, Worth HM. Hereditary enamel hypo-
plasia: its association with characteristic hair structure. Pediatrics. 
1966;37:498-502.
4. Price JA, Wright JT, Kula K, Bowden DW, Hart TC. A common 
DLX3 gene mutation is responsible for tricho-dento-osseous syndrome 
in Virginia and North Carolina families. J Med. Genet. 1998;35:825-
28.
5. Quattromani F, Shapiro SD, Young RS, Jorgenson RJ, Parker JW, 
Blumhardt R, et al. Clinical heterogeneity in the tricho-dento-osseous 
syndrome. Hum Genet. 1983;64:116-21.
6. W. K. Seow. Trichodentoosseous (TDO) syndrome: case report and 
literature review. Pediatr Dent. 1993;15:355–61.
7. Shapiro SD, Quattromani FL, Jorgenson RJ, Young RS. Tricho-den-
to-osseous syndrome: heterogeneity or clinical variability. Am J Med 
Genet. 1983;16:225-36.
8. Viale-Bouroncle S, Felthaus O, Schmalz G, Brockhoff G, Reichert 
TE, Morsczeck C, et al. The transcription factor DLX3 regulates the 
osteogenic differentiation of human dental follicle precursor cells. 
Stem Cells Dev. 2012;21:1936-47.
9. Di Costanzo A, Festa L, Roscigno G, Vivo M, Pollice A, Morasso 
M, et al. A dominant mutation etiologic for human tricho-dento-os-
seous syndrome impairs the ability of DLX3 to downregulate ΔNp63α. 
J Cell Physiol. 2011;226:2189-97. 
10. Zhao N, Han D, Liu Y, Li Y, Zeng L, Wang Y, et al. DLX3 nega-
tively regulates osteoclastic differentiation through microRNA-124. 
Exp Cell Res. 2016;341:166-76.
11. Isaac J, Erthal J, Gordon J, Duverger O, Sun HW, Lichtler AC, 
et al. DLX3 regulates bone mass by targeting genes supporting os-
teoblast differentiation and mineral homeostasis in vivo. Cell Death 
Differ. 2014;21:1365-76.
12. Zhang Z, Tian H, Lv P, Wang W, Jia Z, Wang S, et al. Transcrip-
tional factor DLX3 promotes the gene expression of enamel matrix 
proteins during amelogenesis. PLoS One. 2015;10:e0121288.
13. Mayer DE, Baal C, Litschauer-Poursadrollah M, Hemmer W, Ja-
risch R. Uncombable hair and atopic dermatitis in a case of trichoden-
to-osseous syndrome. J Dtsch Dermatol Ges. 2010;8:102–04. 
14. Nieminen P. DLX3 homeodomain mutations cause tricho-dento-
osseous syndrome with novel phenotypes. Cells Tissues Organs. 
2011;194:49-59.
15. Dong J, Amor D, Aldred MJ, Gu T, Escamilla M, MacDougall 
M. DLX3 mutation associated with autosomal dominant amelogenesis 
imperfecta with taurodontism. Am J Med Genet A. 2005;133:138-41.
Conflict of Interest
The authors have declared that no conflict of interest exist.
